3b Blackbio Dx Ltd · NSE:3BBLACKBIO
3b Blackbio Dx — Kilpest India — Investor Presentation (November 2018)
20 slides from 3b Blackbio Dx's investor presentation, Nov 10, 2018
Slide 1: Cover letter to Bombay Stock Exchange
November 10, 2018 The Relationship Manager, Department of Corporate Relations Bombay Stock Exchange Ltd (BSE), P.J. Towers, Dalal Street Fort, MUMBAI – 400 001 Dear Sir/Madam, Please find the enclosed herewith Investor’s Presentation / Company Update of Agrochemicals and Diagnostic Kits (Health Care
Slide 2: Investor Presentation November 2018
Farmers trusted Agro-input partner for 44 years Reliable & affordable healthcare diagnostics solutions INVESTOR PRESENTATION NOVEMBER 2018
Slide 3: Safe Harbor
Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Kilpest India Limited and 3B BlackBio Biotech India Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to
Slide 4: Kilpest Existing Products
Kilpest Existing Products Chemicals Biologicals No. of Products No. of Products • Insecticides - 70 • Bio pesticide - 07 • Antibacterials - 01 • Bio fungicide - 01 • Fungicides - 15 • Bio fertilizers - 05 • Herbicides - 11 • Bio nematicides - 01 • Public Health - 11 • Public Health - 02 • Microferti
Slide 5: Business Overview and Strengths
Business Overview and Strengths Experienced team & state of art facility located in center of India- with GST implementation this should give a boost to the company • 46yrs old Pesticide Formulation Company, well established in central India, strong brand equity in central India especially in Madhya
Slide 6: Financial Performance: Key Highlights
Financial Performance : Key Highlights -0.32% Q2FY18, KILPEST (Consolidated) Q2 FY19 Q2FY18 FY18 786.80 Q2FY19, 153.33 15.32% Net sales (net of Excise duty) 784.28 786.80 2321.27 Q2 FY19, Q2FY18, Profit before tax 203.71 175.25 451.6 784.28 132.96 Profit after tax 153.33 132.96 342.61 Paid up Equity
Slide 7: Present Market Overview/Outlook
Present Market Overview/Outlook •This year monsoon has been below normal, affecting sales of company. •This year has been bad in history of Agrochemicals, in terms of shortage and increase in raw material •prices, which affected company’s profitability. •Company has entered in Rate Contract with Cen
Slide 8: Financial Highlights- 3B BlackBio Biotech (Q2 FY19)
Financial Highlights- 3B BlackBio Biotech (Q2 FY19) 39.70% 180.52 34.23% 289.08 134.48 206.92 Q2 FY19 Q2 FY19 Q2 FY18 Q2 FY18 Revenue EBITDA 179.01 48.74% 50.69% 133.39 120.35 88.52 Q2 FY19 Q2 FY19 Q2 FY18 Q2 FY18 PBT Rs. In Lakhs. PAT BCR ABL I JAK 2 I PML RARA I KRAS I HLA B27 I MDR TB I H1N1 Deng
Slide 9: Industry Potential- Molecular Diagnostics
Industry Potential- Molecular Diagnostics Highest Growth Rate • The global IVD Market US$ 54.7 billion in the year 2015 (CAGR of 5-6%)1 • Molecular Diagnostic Market US$ 7 billion (CAGR of 10-15%)2 • The current market size for next generation diagnostics (including molecular diagnostics) in India v
Slide 10: Molecular Diagnostics
Molecular Diagnostics • The process of identifying a disease by studying molecules, such as proteins, DNA, and RNA, in a tissue or fluid. • Molecular diagnostics is a technique used to analyze biological markers in the genome and proteome—the individual’s genetic code and how their cells express the
Slide 11: Demand drivers for the Indian Diagnostic Industry
Demand drivers for the Indian Diagnostic Industry • Increased focus on advanced diagnostics • changing costs and quality of healthcare, • rising medical tourism, • evolution of disease profiles, • technology as a driving force, • increase in evidence-based treatments / Drug response monitoring • cha
Slide 12: Winning Strategy
Winning Strategy • Proprietary kits designed, developed & validated in-house • Well accepted assays across wide customer base PAN India • Continuous R&D initiatives for International quality product • Wide range of Diagnostic kits- Infectious, Oncology & Genetics • Import substitution with price adv
Slide 13: New Customers added in Q2 2018-19
New Customers added in Q2 2018-19 Genetic Laboratory Pune Medical College Ludhiana Medical College Amritsar Standalone Diagnostic Laboratory Hyderabad Standalone Diagnostic Laboratory Delhi Standalone Diagnostic Laboratory Jaipur Standalone Diagnostic Laboratory Lucknow Standalone Diagnostic Laborat
Slide 14: New Products Launched in Q2 2018-19
New Products Launched in Q2 2018-19 • TRUPCR® Zika virus - Detection Kit Detection of Zika virus on real-time PCR • TRUPCR® AML Panel Kit - Qualitative detection of diagnostic markers (AML1-ETO, CBFB-MYH11, BCR-ABL1 and PML-RARA) and prognostic markers (FLT3, ITD/TKD, C-KIT and NPM1) of acute myelog
Slide 15: Products in Pipeline
Products in Pipeline • Respiratory Panel - Detection of influenza A virus, influenza B virus, influenza C virus, influenza A(H1N1) swl virus, human parainfluenza viruses 1, 2, 3 and 4 ; human coronaviruses NL63, 229E, OC43 and HKU1; human metapneumoviruses A/B, human rhinovirus, human respiratory sy
Slide 16: Contractual Business
Contractual Business • We are happy to inform that the Company to ensure long term assured business, has started signing long term (2-3 yr) contract with large customers. • As on date the company has five contracts running out of which 1 have been executed in this quarter which ensures yearly busine
Slide 17: Facility Expansion
Facility Expansion Next Gen Sequencing (NGS) Facility Cell Culture Facility • Company is exploring opportunities into Clinical Genetics • Availability of specific Cell lines is very crucial, costly & and has acquired a Next-Generation Sequencing System limited in Molecular Diagnostic research (NGS)
Slide 18: PCR based Molecular Diagnostic Kits
PCR based Molecular Diagnostic Kits
Slide 19: Other Molecular Biology Products
Other Molecular Biology Products Our Life science Product Range- • PCR Enzymes • PCR Master Mixes • Real time PCR Master Mixes • Reverse Transcription PCR Enzymes • Reverse Transcription PCR Master Mixes • dNTPs • Molecular Biology Reagents • Reagents for Electrophoresis • DNA Markers • Nucleic Acid
Slide 20: Kilpest India Limited / 3B BlackBio Biotech India Limited
For further information, please contact: KILPEST INDIA LIMITED 3B BLACKBIO BIOTECH INDIA LIMITED 7-C Industrial Area , Govindpura, Bhopal- 462023[M.P.] INDIA 7-C Industrial Area , Govindpura, Bhopal- 462023 [M.P.] INDIA Phone :: +91-755-2586536 Phone :: +91-755-4077847 Fax :: +91-755-2580438 Fax ::
Kilpest India — Investor Presentation (November 2018) on 6ix